A Comparison of Parenting Education Approaches for Adolescent Fathers

Condition:   Adolescent, Parenting
Intervention:   Behavioral: Parenting Education
Sponsor:   University of Missouri, Kansas City
Not yet recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 22, 2019Comments OffAdolescent | Approaches | Comparison | Education | Fathers | Parenting
Hypertension Management in Cancer Patients

Conditions:   Blood Pressure;   Hypertension;   Cancer;   Cancer, Breast;   Cancer of Prostate;   CLL;   Hematopoietic Malignancy
Intervention:   Other: Automated Messaging
Sponsors:   Duke University;   Duke Institute for Health Innovation
Not yet recruiting
ClinicalTrials.gov: Devices | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 22, 2019Comments OffCancer | Hypertension | Management | Patients
A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer

Condition:   Prostate Cancer
Interventions:   Drug: CTT1403;   Drug: CTT1057 or 68Ga-PSMA-11
Sponsors:   Cancer Targeted Technology;   University of California, San Francisco
Recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 21, 2019Comments OffCancer | Castration | CTT1403 | Metastatic | Prostate | Resistant | Trial
the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer

Conditions:   Endometrial Cancer;   Overweight
Intervention:   Behavioral: Profile by Sanford weight management plan
Sponsor:   Sanford Health
Recruiting
ClinicalTrials.gov: Gynecology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 21, 2019Comments OffCancer | Completed | Effectiveness | Endometrial | Management | Patients | Program | Treatment | Weight
WILD 5 Wellness: A 30-Day Intervention for Residents

Conditions:   Resident Wellness;   Burnout, Professional;   Medical Residents;   Mental Health Wellness 1;   Mental Health Disorder;   Resident Physician
Intervention:   Behavioral: Wellness
Sponsor:   Orange Park Medical Center
Recruiting
ClinicalTrials.gov: Nutrition | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 21, 2019Comments Off30day | Intervention | Residents | Wellness | Wild
A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Subjects With Atopic Dermatitis (AD)

Condition:   Atopic Dermatitis
Intervention:   Biological: Nemolizumab
Sponsor:   Galderma R&D
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 21, 2019Comments OffAdolescent | Atopic | Dermatitis | Nemolizumab | Pharmacokinetics | Safety | Study | Subjects
Phase I Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant

Condition:   Polio
Interventions:   Biological: dmLT;   Biological: fIPV
Sponsor:   University of Vermont
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 21, 2019Comments OffAdjuvant | Coli | dmLT | Double | Enterotoxigenic | Escherichia | Evaluation | fIPV | Fractionaldose | Given | Heat | Immunogenicity | Inactivated | Intradermally | Labile | Mutant | Phase | Polio | Reactogenicity | Safety | Toxin | Vaccine
Study of HPN536 in Patients With Advanced Cancers Associated With Mesothelin Expression

Condition:   Advanced Cancers Associated With Mesothelin Expression
Intervention:   Biological: HPN536
Sponsor:   Harpoon Therapeutics
Recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 21, 2019Comments OffAdvanced | Associated | Cancers | Expression | HPN536 | Mesothelin | Patients | Study
the Safety and Tolerability of Proxalutamide (GT0918) in Subjects With Metastatic Castrate Resistant Prostate Cancer

Condition:   Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Intervention:   Drug: GT0918
Sponsor:   Suzhou Kintor Pharmaceutical Inc,
Not yet recruiting
ClinicalTrials.gov: Hematology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 21, 2019Comments OffCancer | Castrate | GT0918 | Metastatic | Prostate | Proxalutamide | Resistant | Safety | Subjects | Tolerability